Tekturna HCT and Breastfeeding

The manufacturer of Tekturna HCT (aliskiren-HCTZ) does not recommend that women use this drug while breastfeeding. Tekturna HCT contains two medications: aliskiren and hydrochlorothiazide. Although no studies have been done on aliskiren and breastfeeding in humans, it is known that this drug passes through breast milk in rats. Hydrochlorothiazide does pass through breast milk in humans and may decrease a woman's milk supply.

Tekturna HCT Drug Information

Tekturna HCT and Breastfeeding: An Overview

Tekturna HCT^® (aliskiren-HCTZ) passes through breast milk. The manufacturer recommends that women avoid this drug while breastfeeding. If you are breastfeeding or are thinking about breastfeeding, talk with your healthcare provider before taking Tekturna HCT.

Tekturna HCT and Breastfeeding: What Does the Research Say?

Tekturna HCT contains two different medications: aliskiren (Tekturna^®) and hydrochlorothiazide (also known as HCTZ or HCT).

No studies have been done to see if aliskiren passes through breast milk in women. However, it has been shown to pass through breast milk in rats, which is a good indication that it does so in humans as well. Hydrochlorothiazide does pass through breast milk in low amounts (probably too low to affect a breastfed infant). However, there is some concern that hydrochlorothiazide could decrease a woman's milk supply.

Talking With Your Healthcare Provider About Tekturna HCT and Breastfeeding

You should talk with your healthcare provider about Tekturna HCT and breastfeeding.

Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Tekturna HCT and breastfeeding that is right for you.